跳至主要内容
临床试验/NCT03048617
NCT03048617已完成不适用

A Prospective Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)

Stealth BioTherapeutics Inc.33 个研究点 分布在 9 个国家目标入组 215 人开始时间: 2017年2月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
215
试验地点
33
主要终点
Assess the relationship of genotype to phenotype in patients with Primary Mitochondrial Disease

研究概览

简要总结

This is an observational study of patients with Primary Mitochondrial Disease with either signs or symptoms suggestive of myopathy. The Investigator will identify potential patients through existing medical records and one on-site visit.

详细描述

An observational study of patients with presumed Primary Mitochondrial Disease designed to better characterize and correlate symptoms and signs of myopathy and genetic test results and the use of commonly prescribed treatments. The study will help define and identify a subject population for a future trial of an investigational product to treat primary mitochondrial disease associated with signs and symptoms of myopathy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to provide a signed informed consent form (ICF) prior to participation in any-trial related procedures
  • Patient has clinical presentation of PMD with either signs or symptoms suggestive of myopathy
  • Patient is ambulatory and able to attempt 6MWT

排除标准

  • Patient has symptoms of PMD due to secondary mitochondrial dysfunction
  • Patient has had prior exposure to elamipretide
  • Patient does not have the cognitive capacity to understand and complete all study assessments
  • Patient has a medical history of severe renal impairment
  • History of active alcoholism or drug addiction during the year before enrollment

结局指标

主要结局

Assess the relationship of genotype to phenotype in patients with Primary Mitochondrial Disease

时间窗: 1 year

Compare local and regional differences in standard of care and management of patients with Primary Mitochondrial Disease

时间窗: 1 year

次要结局

  • Compare local and regional differences in genetic testing methodologies for Primary Mitochondrial Disease(1 year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (33)

Loading locations...

相似试验

An Observational Study of Patients With Primary... | 临床试验